Pharma Pulse 3/8/24: Lilly's New Campaign Challenges Misperceptions About Obesity Care, Challenges Facing Broader Adoption of Novel Cell and Gene Therapies & more

The Biggest Challenges Facing Broader Adoption of Novel Cell and Gene Therapies

In this Pharmaceutical Executive video interview, Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, discusses the biggest challenges facing the broader adoption of novel cell and gene therapies from IQVIA's Global Trends in R&D 2024 report.

Addressing CAR T Challenges: Enhancing Collaboration for Patient Care

Knowledge gaps persist in awareness of and education on the use of chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, especially multiple myeloma and lymphoma.

Top Senators Urge Stores to Stop Selling Illicit Vapes

Lawmakers want shopkeepers to remove e-cigarettes that were not authorized by the F.D.A. Retailers say it is not that simple.

Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care

Eli Lilly and Company launched the next phase of its Get Better corporate branding campaign with a new focus on obesity. Earlier this year, Lilly launched Get Better to reinforce its commitment to discovering and making medicines that give people a chance at better health.

@FiercePharma on Twitter/X:

Boehringer Ingelheim cuts monthly out-of-pocket inhaler prices to $35 for US patients

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs